| Entry |
|
| Name |
Galantamine (USAN/INN);
Reminyl (TN)
|
| Formula |
C17H21NO3
|
| Exact mass |
287.1521
|
| Mol weight |
287.3535
|
| Structure |

     |
| Source |
Galanthus woronowii [TAX: 197699]
|
| Activity |
Alzheimer's disease treatment [cholinesterase inhibitor] [DS: H00056]
|
| Remark |
|
| Target |
acetylcholinesterase (AChE) inhibitor [HSA: 43] [KO: K01049]; nicotinic acetylcholine receptor (nAChR) allosteric site agonist |
| Pathway |
|
| Interaction |
Genomic biomarker: CYP2D6 [HSA: 1565]
 |
| Structure map |
| Cholinergic and anticholinergic drugs |
|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N06 PSYCHOANALEPTICS
N06D ANTI-DEMENTIA DRUGS
N06DA Anticholinesterases
N06DA04 Galantamine
D04292 Galantamine (USAN/INN)
USP drug classification [BR:br08302]
Antidementia Agents
Cholinesterase Inhibitors
Galantamine
D04292 Galantamine (USAN/INN)
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases
acetylcholinesterase (AChE) [HSA:43] [KO:K01049]
Galantamine [ATC:N06DA04]
D04292 Galantamine (USAN/INN)
 |
| Other DBs |
CAS: 357-70-0 PubChem: DrugBank: PDB-CCD: LigandBox: NIKKAJI: |
| KCF data |
 ATOM 21
1 C8y C 26.6000 -12.1800
2 C1x C 27.6500 -12.9500
3 N1y N 28.9800 -12.6700
4 C1x C 29.5400 -11.4100
5 C8y C 26.6000 -10.7800
6 C1x C 28.9800 -10.2200
7 C1z C 27.6500 -9.7300
8 C1a C 29.8900 -13.7200
9 C8x C 25.4100 -12.8800
10 C8x C 24.2200 -12.1800
11 C8y C 24.2200 -10.7800
12 C8y C 25.4100 -10.0800
13 O2a O 23.0300 -10.1500
14 O2x O 25.7600 -8.4700
15 C1y C 27.1600 -8.4000
16 C1x C 27.7900 -7.2800
17 C1y C 29.1900 -7.2800
18 C2x C 29.8900 -8.4700
19 C2x C 29.1900 -9.7300
20 O1a O 29.8900 -6.0200
21 C1a C 21.8441 -10.8940
BOND 24
1 3 4 1
2 1 5 2
3 4 6 1
4 2 3 1
5 5 7 1
6 1 2 1
7 7 6 1 #Down
8 3 8 1
9 1 9 1
10 9 10 2
11 10 11 1
12 11 12 2
13 5 12 1
14 11 13 1
15 12 14 1
16 14 15 1
17 7 15 1
18 15 16 1
19 16 17 1
20 17 18 1
21 7 19 1
22 19 18 2
23 17 20 1 #Up
24 13 21 1
|